Prevalence of MRSA in Emergency and Elective Patients Admitted to a Vascular Surgical Unit: Implications for Antibiotic Prophylaxis

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 4, 2006, Pages 402-407

  Muralidhar, B ^a   Anwar, S M ^a   Handa, A I ^a   Peto, T E A ^b   Bowler, I C J W ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Departments of Infectious Diseases

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Antibiotic prophylaxis; MRSA screening; Vascular surgery

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFUROXIME; GENTAMICIN; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL DECISION MAKING; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; STAPHYLOCOCCUS INFECTION; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; DECISION SUPPORT TECHNIQUES; EMERGENCY TREATMENT; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL PROCEDURES, ELECTIVE; VASCULAR SURGICAL PROCEDURES;

EID: 33748467162     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.03.015     Document Type: Article

References (37)

1. Bunt T.J. Synthetic vascular graft infections. I. Graft infections. Surgery 93 6 (1983) 733-746
2. Hicks R.C., and Greenhalgh R.M. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg 14 Suppl. A (1997) 5-9
3. Zdanowski Z., Danielsson G., Jonung T., et al. Intraoperative contamination of synthetic vascular grafts. Effect of glove change before graft implantation. A prospective randomised study. Eur J Vasc Endovasc Surg 19 3 (2000) 283-287
4. Voss A., Milatovic D., Wallrauch-Schwarz C., Rosdahl V.T., and Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13 1 (1994) 50-55
5. Folorunso A.B.A.-D.F., Lyon D.J., and Cheng A.F. Living with methicillin-resistant Staphylococcus aureus: a 7-years experience with MRSA in a university hospital. Infect Control Hosp Epidemiol 18 (2000) 765-767
6. Adcock P.M., Pastor P., Medley F., Patterson J.E., and Murphy T.V. Methicillin-resistant Staphylococcus aureus in two child care centres. J Infect Dis 178 2 (1998) 577-580
7. Maguire G.P., Arthur A.D., Boustead P.J., Dwyer B., and Currie B.J. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect 38 4 (1998) 273-281
8. Wyllie D.H., Peto T.E., and Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. BMJ 331 7523 (2005) 992
9. Naylor A.R., Hayes P.D., and Darke S. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg 21 4 (2001) 289-294
10. Surveillance of Surgical Site Infection in English Hospitals. Nosocomial Infection National Surveillance Service (NINSS), 1997-2002.
11. Earnshaw J.J. Methicillin-resistant Staphylococcus aureus: vascular surgeons should fight back. Eur J Vasc Endovasc Surg 24 4 (2002) 283-286
12. UK MRSA Guidelines 'Combined Working Party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses. J Hosp Infect 39 (1998) 253-290
13. Scriven J.M., Silva P., Swann R.A., et al. The acquisition of methicillin-resistant Staphylococcus aureus (MRSA) in vascular patients. Eur J Vasc Endovasc Surg 25 2 (2003) 147-151
14. Rubinovitch B., and Pittet D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?. J Hosp Infect 47 1 (2001) 9-18
15. Antibacterial prophylaxis in surgery: 3 - Arterial surgery in the abdomen, pelvis and lower limbs. Drug Ther Bull 42 6 (2004) 43-47
16. Jensen L.J., Aagaard M.T., and Schifter S. Prophylactic vancomycin versus placebo in arterial prosthetic reconstructions. Thorac Cardiovasc Surg 33 5 (1985) 300-303
17. Fraise A.P. Guidelines for the control of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 42 3 (1998) 287-289
18. Recommendations of the Hospital Infection Control Practices Advisory Committee(HICPAC). Recommendations for preventing the spread of vancomycin resistance. MMWR Recomm Rep 44 Suppl. RR-12 (1995) 1-13
19. Gemmell C.G., Edwards D.I., Fraise A.P., Gould F.K., Ridgeway G.L., and Warren R.E. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Anntimicrob Chemother (2006) [Advance Access published February 27]
20. Fraise A.P. The treatment and control of vancomycin resistant enterococci. J Antimicrob Chemother 38 5 (1996) 753-756
21. Levy J.H., Kettlekamp N., Goertz P., Hermens J., and Hirshman C.A. Histamine release by vancomycin: a mechanism for hypotension in man. Anesthesiology 67 1 (1987) 122-125
22. Dajee H., Laks H., Miller J., and Oren R. Profound hypotension from rapid vancomycin administration during cardiac operation. J Thorac Cardiovasc Surg 87 1 (1984) 145-146
23. Kucers A., Crowe S.M., Grayson M.L., and Hoy J.F. The use of antibiotics. 5th ed. (1997), Butterworth Heinemann, Oxford 450-488
24. Henwood C.J., Livermore D.M., Johnson A.P., James D., Warner M., and Gardiner A. Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. J Antimicrob Chemother 46 6 (2000) 931-940
25. Wenzel R.P. Preoperative antibiotic prophylaxis. N Engl J Med 326 5 (1992) 337-339
26. Investigation of specimens for screening for MRSA.B.SOP 29. www.hpa.org.uk
27. Garner J.S., Jarvis J.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions of nosocomial infections. In: Olmsted R.N. (Ed). AIPC infection control and applied epidemiology: principles and practice (1996), Mosby, London A1-A20
28. Hammond C.J., Gill J., Peto T.E., Cadoux-Hudson T.A., and Bowler I.C. Investigation of prevalence of MRSA in referrals to neurosurgery: implications for antibiotic prophylaxis. Br J Neurosurg 16 6 (2002) 550-554
29. Salzman G. Perioperative infection prophylaxis in vascular surgery - a randomised prospective study. Thorac Cardiovasc Surg 31 4 (1983) 239-242
30. Kaiser A.B., Clayson K.R., Mulherin Jr. J.L., Roach A.C., Allen T.R., Edwards W.H., et al. Antibiotic prophylaxis in vascular surgery. Ann Surg 188 (1978) 283-289
31. Pitt H.A., Postier R.G., MacGowan A.W., Frank L.W., Surmak A.J., Sitzman J.V., et al. Prophlactic antibiotics in vascular surgery. Topical, systemic, or both?. Ann Surg 192 (1980) 356-364
32. Worning A.M., Frimodt-Moller N., Ostri P., Nilsson T., Hojholdt K., and Frimodt-Moller C. Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo-controlled study. J Antimicrob Chemother 17 (1986) 105-113
33. Doebbeling B.N. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 7 Suppl. 3 (1995) 99-103
34. Wenzel R.P., and Perl T.M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 31 1 (1995) 13-24
35. Plowman R., Graves N., Griffin M., Roberts J.A., Swan A.V., Cookson B., et al. The socio - economic burden of hospital acquired infection. Public Health Lab Serv (1999)
36. Cepeda J.A., Whitehouse T., Cooper B., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365 9456 (2005) 295-304
37. Johnson A.P., Pearson A., and Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 56 3 (2005) 455-462